JB CHEMICALS & PHARMACEUTICALS
|
|
| BOM : 506943     NSE : JBCHEPHARM     | |
| LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
| ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward Pledged Shares : None or < 25% |
Feb 20,2026 |
|
Price(EOD): ₹ 2,001.25
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
| MCap: ₹ 32,140.08 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| JB CHEMICALS & PHARMACEUTICALS | 5.1% | 5.6% | 17.7% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.9% | 6.2% | -1.3% |
| DIVIS LABORATORIES | 2% | 4.8% | 4.6% |
| CIPLA | -0.1% | -3% | -8.4% |
| TORRENT PHARMACEUTICALS | 3.6% | 6% | 36.9% |
| DR REDDYS LABORATORIES | 1% | 10.8% | 4.7% |
| MANKIND PHARMA | -1.1% | -3% | -16.9% |
| ZYDUS LIFESCIENCES | -0.3% | 3% | -3.4% |
| LUPIN | 1.3% | 4.2% | 8.3% |
FUNDAMENTAL ANALYSIS OF JB CHEMICALS & PHARMACEUTICALS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF JB CHEMICALS & PHARMACEUTICALS
 | Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
42.63
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 753.78 Cr
[Latest Qtr - Dec2025 - Consolidated Results ] 9.84
P/B Calculated based on Book Value of Rs 3,265.29 Cr
[Latest Year - Mar2025 - Consolidated Results ] 7.66
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 4,193.04 Cr
[Latest Qtr - Dec2025 - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
192% 205% 196% |
SHARE PRICE MOMENTUM OF JB CHEMICALS & PHARMACEUTICALS
JB CHEMICALS & PHARMACEUTICALS vs SENSEX
DEBT OF JB CHEMICALS & PHARMACEUTICALS
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2025 2024 2023 Avg_3yrs |
0 0.12 0.23 0.12 |
0 0.13 0.23 0.12 |
|
[Last Annual Data : Mar2025]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF JB CHEMICALS & PHARMACEUTICALS
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Dec2025 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF JB CHEMICALS & PHARMACEUTICALS
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
-1.86% -4.45% -4.4% -4.78% |
10.51% 16.23% 22.42% 21.79% |
| QtrlyTrend |
0 | |
| Latest Qtr: Dec2025 | ||
| Quarterly Result Analysis → | ||
JB CHEMICALS & PHARMACEUTICALS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE 500 SHARIAH | 4.3% | 4.3% | 1.1% |
| BSE HEALTHCARE | 1.1% | 4.2% | 5% |
| BSE SMALLCAP SELECT INDEX | 0.4% | 2.4% | 11.3% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY MNC | 1.3% | 4.3% | 19.2% |
| NIFTY PHARMA | 1.2% | 4% | 4.8% |
| NIFTY 500 | 0.4% | 2.5% | 11.9% |
| NIFTY TOTAL MARKET | 0.3% | 2.5% | 11.5% |
| NIFTY500 MULTICAP 50:25:25 | 0.2% | 2.7% | 11.6% |
You may also like the below Video Courses
FAQ about JB CHEMICALS & PHARMACEUTICALS
Is JB CHEMICALS & PHARMACEUTICALS good for long term investment?
As on Feb 20,2026, the Fundamentals of JB CHEMICALS & PHARMACEUTICALS look Strong and hence it may be good for long term investment! See Financial Performance of JB CHEMICALS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is JB CHEMICALS & PHARMACEUTICALS UnderValued or OverValued?
As on Feb 20,2026, JB CHEMICALS & PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of JB CHEMICALS & PHARMACEUTICALS ?
As on Feb 20,2026, the Intrinsic Value of JB CHEMICALS & PHARMACEUTICALS is Rs. 676.53 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 684.30
Fair Value [Median EV / Sales Model] : Rs. 655.62
Fair Value [Median Price / Sales Model] : Rs. 676.53
Estimated Median Fair Value of JB CHEMICALS & PHARMACEUTICALS : Rs. 676.53
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.